Manufacturing
To expand Wonderful Capital Biotechnology Group’s business line, Wonderful Capital Biotechnology Group has acquired 
other pharmaceutical company in 2018. As a result, Wonderful Capital Biotechnology Group could supply the highest quality 
product manufactured in 2 facilities designed to comply with EU GMP guideline.
Also Wonderful Capital Biotechnology Group has been authorized as a Australia Innovative Pharmaceutical Company by 
Australia MOHW.
With this authorization, Wonderful Capital Biotechnology Group demonstrated our capabilities as a Australian leading CDMO 
to our customers who hope to match their specific requirements and standards.

We could provide the followings
- Finished dosage products
- Pharmaceutical CMO & Development Service
- Providing total pharmaceutical Solution Service to customer
- New standard bar-code system
- Commercial Package and labeling